ATG-032

N/A

Report date: 2022/01/06 15:21:10

Base Information

Drug NameATG-032
Drug Alias NameATG-032
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-LILRB
TargetsLeukocyte immunoglobulin-like receptor subfamily B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAntengene Corporation Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAntengene Corporation Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A